RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Repayments of term debt

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndRepayments of term debt (Million USD)YoY (%)
Dec 31, 20241,641-60.48%
Dec 31, 20234,152+203.29%
Dec 31, 20221,369-79.41%
Dec 31, 20216,649+255.37%
Dec 31, 20201,871-52.56%
Dec 31, 20193,944-47.03%
Dec 31, 20187,446+125.64%
Dec 31, 20173,300+230.33%
Dec 31, 2016999-60.37%
Dec 31, 20152,521+200.48%
Dec 31, 2014839-73.22%
Dec 31, 20133,133+41.57%
Dec 31, 20122,213+194.67%
Dec 31, 2011751-61.92%
Dec 31, 20101,972

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)